Drug‑loaded nano‑microcapsules delivery system mediated by ultrasound‑targeted microbubble destruction: A promising therapy method (Review)

  • Authors:
    • Jing Ma
    • Lian Fang Du
    • Ming Chen
    • Hang Hui Wang
    • Ling Xi Xing
    • Li Fang Jing
    • Yun Hua Li
  • View Affiliations

  • Published online on: May 21, 2013     https://doi.org/10.3892/br.2013.110
  • Pages: 506-510
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The nano‑microcapsules drug delivery system is currently a promising method for the treatment of many types of diseases, particularly tumors. However, the drug delivery efficiency does not reach a satisfactory level to meet treatment demands. Therefore, the effectiveness of delivery needs to be improved. Based on the alterations in the structure and modification of nano‑microcapsules, ultrasound‑targeted microbubble destruction (UTMD), a safe physical targeted method, may increase tissue penetration and cell membrane permeability, aiding the drug‑loaded nano‑microcapsules ingress the interior of targeted tissues and cells. The effectiveness and exact mechanism of action of the drug‑loaded nano‑microcapsules delivery system mediated by UTMD have yet to be fully elucidated. In this study, the latest advancement in UTMD‑mediated drug loaded nano‑microcapsules system technology was reviewed and the hindrances of UTMD‑mediated drug delivery were assessed, in combination with a prospective study. The findings suggested that the drug delivery efficiency of nano‑microcapsules mediated by UTMD was distinctly improved. Thus, the UTMD‑mediated drug‑loaded nano‑microcapsules delivery system may significantly improve the efficiency of drug delivery, which may be a promising new therapeutic method.

References

1 

Yang K, Feng L, Shi X and Liu Z: Nano-graphene in biomedicine: theranostic applications. Chem Soc Rev. 10:530–547. 2013. View Article : Google Scholar : PubMed/NCBI

2 

Eldar-Boock A, Miller K, Sanchis J, et al: Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel. Biomaterials. 32:3862–3874. 2011. View Article : Google Scholar : PubMed/NCBI

3 

Yang SJ, Chang SM, Tsai KC, et al: Effect of chitosan-alginate nanoparticles and ultrasound on the efficiency of gene transfection of human cancer cells. J Gene Med. 12:168–179. 2010.PubMed/NCBI

4 

Chappell JC, Song J, Burke CW, et al: Targeted delivery of nanoparticles bearing fibroblast growth factor-2 by ultrasonic microbubble destruction for therapeutic arteriogenesis. Small. 4:1769–1777. 2008. View Article : Google Scholar

5 

Park HJ, Lee J, Kim MJ, et al: Sonic hedgehog intradermal gene therapy using a biodegradable poly(β-amino esters) nanoparticle to enhance wound healing. Biomaterials. 33:9148–9156. 2012.PubMed/NCBI

6 

Kummitha CM, Malamas AS and Lu ZR: Albumin pre-coating enhances intracellular siRNA delivery of multifunctional amphiphile/siRNA nanoparticles. Int J Nanomedicine. 7:5205–5214. 2012.PubMed/NCBI

7 

Fields RJ, Cheng CJ, Quijano E, et al: Surface modified poly(β-amino ester)-containing nanoparticles for plasmid DNA delivery. J Control Release. 164:41–48. 2012.

8 

Kumari A, Yadav SK and Yadav SC: Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces. 75:1–18. 2010. View Article : Google Scholar : PubMed/NCBI

9 

Kang BC, Kang KS and Lee YS: Biocompatibility and long-term toxicity of lnnoPol implant a biodegradable polymer scaffold. Exp Anim. 54:37–52. 2005. View Article : Google Scholar : PubMed/NCBI

10 

Itaka K, Ishii T, Hasegawa Y and Kataoka K: Biodegradable polyamino acid-based polycations as safe and effective gene carrier minimizing cumulative toxicity. Biomaterials. 31:3707–3714. 2010. View Article : Google Scholar : PubMed/NCBI

11 

Jere D, Jiang HL, Arote R, et al: Degradable polyethylenimines as DNA and small interfering RNA carriers. Expert Opin Drug Deliv. 6:827–834. 2009. View Article : Google Scholar : PubMed/NCBI

12 

Nounou MI, Emmanouil K, Chung S, et al: Novel reducible linear L-lysine-modified copolymers as efficient nonviral vectors. J Control Release. 143:326–334. 2010. View Article : Google Scholar : PubMed/NCBI

13 

Zhang Y, Chan HF and Leong KW: Advanced materials and processing for drug delivery: The past and the future. Adv Drug Deliv Rev. 65:104–120. 2012. View Article : Google Scholar : PubMed/NCBI

14 

Duan Y, Xu J, Lin Y, et al: A preliminary study on MeO-PEG- PLGA-PEG-OMe nanoparticles as intravenous carriers. J Biomed Mater Res A. 87:515–523. 2008. View Article : Google Scholar : PubMed/NCBI

15 

Brazeau GA, Sciame M, al-Suwayeh SA and Fattal E: Evaluation of PLGA microsphere size effect on myotoxicity using the isolated rodent skeletal muscle model. Pharm Dev Technol. 1:279–283. 1996. View Article : Google Scholar : PubMed/NCBI

16 

Falamarzian A and Lavasanifar A: Optimization of the hydrophobic domain in poly(ethylene oxide)-poly(varepsiloncaprolactone) based nano-carriers for the solubilization and delivery of Amphotericin B. Colloids Surf B Biointerfaces. 81:313–320. 2010. View Article : Google Scholar : PubMed/NCBI

17 

Gabler F, Frauenschuh S and Ringe J: Emulsion-based synthesis of PLGA-microspheres for the in vitro expansion of porcine chondrocytes. Biomol Eng. 24:515–520. 2007. View Article : Google Scholar : PubMed/NCBI

18 

Falamarzian A and Lavasanifar A: Chemical modification of hydrophobic block in poly(ethylene oxide) poly(caprolactone) based nanocarriers: effect on the solubilization and hemolytic activity of amphotericin B. Macromol Biosci. 10:648–656. 2010. View Article : Google Scholar

19 

Fan L, Li F, Zhang H, Wang Y, Cheng C, Li X, Gu CH, Yang Q, Wu H and Zhang S: Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance. Biomaterials. 31:5634–5642. 2010. View Article : Google Scholar : PubMed/NCBI

20 

Chen M, Cooper HM, Zhou JZ, et al: Reduction in the size of layered double hydroxide nanoparticles enhances the efficiency of siRNA delivery. J Colloid Interface Sci. 390:275–281. 2013. View Article : Google Scholar : PubMed/NCBI

21 

Du J, Shi QS, Sun Y, Liu PF, Zhu MJ, Du LF and Duan YR: Enhanced delivery of monomethoxypoly(ethylene glycol)- poly(lactic-co-glycolic acid)-poly l-lysine nanoparticles loading platelet-derived growth factor BB small interfering RNA by ultrasound and/or microbubbles to rat retinal pigment epithelium cells. J Gene Med. 13:312–323. 2011. View Article : Google Scholar

22 

Duncan R: Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer. 6:688–701. 2006. View Article : Google Scholar : PubMed/NCBI

23 

Lee SH and Shin H: Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Adv Drug Deliv Rev. 59:339–359. 2007. View Article : Google Scholar : PubMed/NCBI

24 

Moghimi SM: Mechanisms of splenic clearance of blood cells and particles: towards development of new splenotropic agents. Adv Drug Deliv Rev. 17:103–115. 1995. View Article : Google Scholar

25 

Nafee N, Taetz S, Schneider M, et al: Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. Nanomedicine. 3:173–183. 2007. View Article : Google Scholar : PubMed/NCBI

26 

Loomis K, Smith B, Feng Y, Garg H, Yavlovich A, Campbell-Massa R, Dimitroy DS, Blumenthal R, Xiao X and Puri A: Specific targeting to B cells by lipid-based nanoparticles conjugated with a novel CD22-ScFv. Exp Mol Pathol. 88:238–249. 2010. View Article : Google Scholar : PubMed/NCBI

27 

Chen Y, Wu JJ and Huang L: Nanoparticles targeted with NGR motif deliver c-myc siRNA and doxorubicin for anticancer therapy. Mol Ther. 18:828–834. 2010. View Article : Google Scholar : PubMed/NCBI

28 

Patil Y and Panyam J: Polymeric nanoparticles for siRNA delivery and gene silencing. Int J Pharm. 367:195–203. 2009. View Article : Google Scholar : PubMed/NCBI

29 

Tahara K, Yamamoto H and Hirashima N: Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects. Eur J Pharm Biopharm. 74:421–426. 2010. View Article : Google Scholar : PubMed/NCBI

30 

Gunaseelan S, Gunaseelan K, Deshmukh M, et al: Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs. Adv Drug Deliv Rev. 62:518–531. 2010. View Article : Google Scholar : PubMed/NCBI

31 

Yoo HS and Park TG: Folate receptor targeted biodegradable polymeric doxorubicin micelles. J Control Release. 96:273–283. 2004. View Article : Google Scholar : PubMed/NCBI

32 

Yoo KS and Park TG: Folate receptor targeted biodegradable polymeric doxorubicin micelles. J Controlled Release. 96:273–283. 2004. View Article : Google Scholar : PubMed/NCBI

33 

de la Fuente M, Seijo B and Alonso MJ: Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy. Invest Ophthalmol Vis Sci. 49:2016–2024. 2008.PubMed/NCBI

34 

Bishop P: The biochemical structure of mammalian vitreous. Eye (Lond). 10:664–670. 1996. View Article : Google Scholar

35 

Prentice P, Cushieri A, Dholakia K, Prausnitz M and Campbell P: Membrane disruption by optically controlled microbubble cavitation. Nat Phys. 1:107–110. 2005. View Article : Google Scholar

36 

Tachlibana K, Uchida T, Ogawa K, et al: Induction of cell- membrane porosity by ultrasound. Lancet. 353:14091999. View Article : Google Scholar : PubMed/NCBI

37 

van Wamel A, Kooiman K, Harteveld M, et al: Vibrating micro-bubbles poking individual cells: drug transfer into cells via sonoporation. J Control Release. 112:149–155. 2006.PubMed/NCBI

38 

Schlicher RK, Radhakrishna H, Tolentino TP, et al: Mechanism of intracellular delivery by acoustic cavitation. Ultrasound Med Biol. 32:915–924. 2006. View Article : Google Scholar : PubMed/NCBI

39 

Juffermans LJ, Dijkmans PA, Musters RJ, et al: Transient permeabilization of cell membranes by ultrasound-exposed microbubbles is related to formation of hydrogen peroxide. Am J Physiol Heart Circ Physiol. 291:H1595–H1601. 2006. View Article : Google Scholar : PubMed/NCBI

40 

Miller DL and Gies RA: The interaction of ultrasonic heating and cavitation in vascular bioeffects on mouse intestine. Ultrasound Med Biol. 24:123–128. 1998. View Article : Google Scholar : PubMed/NCBI

41 

Sonoda S, Tachibana K and Uchino E: Gene transfer to corneal epithelium and keratocytes mediated by ultrasound with micro-bubbles. Invest Ophthalmol Vis Sci. 47:558–564. 2006. View Article : Google Scholar : PubMed/NCBI

42 

Wu Y, Du LF, Chen YD, et al: SonoVue and ultrasound-mediated pEGFP-N1 transfection to mouse cornea in an in vivo study. Chin J Ultrasonogr. 17:350–353. 2008.

43 

Du J, Sun Y, Shi QS, Liu PF, Zhu MJ, Wang CH, Du LF and Duan YR: Biodegradable nanoparticles of mPEG-PLGA-PLL triblock copolymers as novel non-viral vectors for improving siRNA delivery and gene silencing. Int J Mol Sci. 13:516–533. 2012. View Article : Google Scholar : PubMed/NCBI

44 

Chumakova OV, Liopo AV, Andreev VG, et al: Composition of PLGA and PEI/DNA nanoparticles improves ultrasound-mediated gene delivery in solid tumors in vivo. Cancer Lett. 261:215–225. 2008. View Article : Google Scholar : PubMed/NCBI

45 

Hosseinkhani H and Tabata Y: Ultrasound enhances in vivo tumor expression of plasmid DNA by PEG-introduced cationized dextran. J Control Release. 108:540–556. 2005. View Article : Google Scholar : PubMed/NCBI

46 

Rapoport N, Gao Z and Kennedy A: Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J Natl Cancer Inst. 99:1095–1106. 2007. View Article : Google Scholar : PubMed/NCBI

47 

Hauff P, Seemann S, Reszka R, et al: Evaluation of gas-filled microparticles and sonoporation as gene delivery system: feasibility study in rodent tumor models. Radiology. 236:572–578. 2005. View Article : Google Scholar : PubMed/NCBI

48 

Bekeredjian R, Chen S, Frenkel PA, et al: Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation. 108:1022–1026. 2003. View Article : Google Scholar

49 

Torchilin VP: Passive and active drug targeting: drug delivery to tumors as an example. Handb Exp Pharmacol. 197:3–53. 2010. View Article : Google Scholar : PubMed/NCBI

50 

Ke H, Wang J, Dai Z, et al: Gold-nanoshelled microcapsules: a theranostic agent for ultrasound contrast imaging and photo-thermal therapy. Angew Chem Int Ed Engl. 50:3017–3021. 2011. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

July 2013
Volume 1 Issue 4

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Ma, J., Du, L.F., Chen, M., Wang, H.H., Xing, L.X., Jing, L.F., & Li, Y.H. (2013). Drug‑loaded nano‑microcapsules delivery system mediated by ultrasound‑targeted microbubble destruction: A promising therapy method (Review). Biomedical Reports, 1, 506-510. https://doi.org/10.3892/br.2013.110
MLA
Ma, J., Du, L. F., Chen, M., Wang, H. H., Xing, L. X., Jing, L. F., Li, Y. H."Drug‑loaded nano‑microcapsules delivery system mediated by ultrasound‑targeted microbubble destruction: A promising therapy method (Review)". Biomedical Reports 1.4 (2013): 506-510.
Chicago
Ma, J., Du, L. F., Chen, M., Wang, H. H., Xing, L. X., Jing, L. F., Li, Y. H."Drug‑loaded nano‑microcapsules delivery system mediated by ultrasound‑targeted microbubble destruction: A promising therapy method (Review)". Biomedical Reports 1, no. 4 (2013): 506-510. https://doi.org/10.3892/br.2013.110